For long-term investors, valuation is a critical part of the decision-making process. Even an outstanding company can become a poor investment if bought at too high a price, as excessive premiums can erode returns or even lead to losses. Among the many valuation tools available, the forward price-to-earnings ratio (forward P/E) is particularly useful because it incorporates analysts’ earnings forecasts for the coming year. Compared with P/E ratios based solely on past performance, forward P/E often offers a more reliable gauge of a stock’s current value.
At present, several high-quality growth companies are trading at levels that do not fully reflect their long‑term potential, creating what some investors may view as pockets of value. Based on forward P/E analysis, AbbVie (NYSE: ABBV), Micron Technology (NASDAQ: MU) and Adobe (NASDAQ: ADBE) all appear attractive at current prices.
This healthcare company trades at a forward P/E of roughly 16 times, significantly below the S&P 500’s average of about 22 times. More notably, AbbVie’s long‑term price/earnings-to-growth (PEG) ratio stands at around 0.4, far under the commonly cited threshold of 1 that is often seen as a marker of reasonable value. Taken together with growth expectations over the next five years, this suggests that the stock’s valuation advantage is particularly pronounced within the pharmaceutical sector.
AbbVie has built a substantial product pipeline, with about 90 different compounds, devices or indications under investigation, of which roughly 60 projects are already in mid‑ to late‑stage development. Continued high levels of research and development spending underpin the company’s long‑term growth prospects. In the first nine months of the current fiscal year, revenue rose 8% year on year to 44.5 billion USD, while operating income reached 10.5 billion USD. Management expects the company to deliver mid‑ to high‑single‑digit annual growth by the end of this decade.
Despite a strong share price rally over the past 12 months, Micron Technology’s stock still appears inexpensive when viewed against analysts’ growth forecasts. The company currently trades at a forward P/E of just 11 times, with a PEG ratio of 0.6.
The main driver of Micron’s growth is the surge in demand from data centers fueled by the rapid development of artificial intelligence (AI). To concentrate resources, the company has decided to exit key consumer-facing businesses and fully pivot toward enterprise markets. Over the past four quarters, Micron generated 42.3 billion USD in revenue and 11.9 billion USD in net income, implying a profit margin of 28%. Its focus on high‑growth segments such as data centers is expected to further enhance the company’s financial performance in the coming years.
While AI‑related stocks have been in the spotlight, the share price of this design‑software giant has fallen about 19% over the past year, as the market has grown increasingly concerned about its competitive position. Adobe’s forward P/E now stands at just 14 times, and its long‑term PEG ratio is slightly below 1, suggesting that the market may be undervaluing its long‑term prospects.
Despite questions about rising competition from new AI tools, Adobe’s financial results remain solid. In fiscal 2025, revenue climbed 11% year on year to 23.8 billion USD, while net income surged 28% to 7.1 billion USD. With a gross margin of roughly 90%, the company has ample room to adjust pricing if necessary to maintain competitiveness, though its current stable operations indicate no immediate need for such measures. The market’s arguably excessive focus on AI‑related threats may be creating an entry point for growth‑oriented investors to accumulate a high‑quality franchise at a pessimistic valuation.
Investing is not only about finding great companies; it is also about buying them at the right price. By looking through the lens of forward P/E, investors can more clearly identify stocks whose current prices do not fully reflect their future growth potential. AbbVie, Micron Technology and Adobe currently combine attractive valuations with solid business fundamentals and credible growth outlooks, making them candidates that long‑term, growth‑focused investors may wish to examine more closely.
